1. ARVO: Sight set on world-class science.
- Subjects
- *
THERAPEUTIC use of antioxidants , *RETINAL degeneration , *HETEROCYCLIC compounds , *OPHTHALMOLOGY , *CONFERENCES & conventions , *DRY eye syndromes , *ENZYME inhibitors , *GLAUCOMA , *MICROSCOPY , *OPHTHALMIC drugs , *PROTEINS , *RETINAL diseases , *TEARS (Body fluid) , *PREVENTION , *SOCIETIES - Abstract
Information about several papers discussed at the Association for Research in Vision and Ophthalmology (ARVO) meeting in 2013 is presented. Age-Related Eye Disease Study 2 (AREDS2) results showed that participants treated with the antioxidants lutein and zeaxanthin without beta-carotene had their risk of age-related macular degeneration (AMD) reduced at about 18%. Automated standardization in evaluating corneal superficial punctuate keratitis (SPK) is shown not to be invariably applicable.
- Published
- 2013